Anti-microbiote antibodies are contributing to inflammatory bowel diseases diagnostic. Miniaturization and combination of the assays lead to generate a larger set of data and thus to get the immune profile of anti-microbiome.
Key Points of InTest
- Easy to process: the assay is based on an ELISA-like protocol,
- Improved sensitivity and specificity: thanks to assay combination, final results are improved
- Up to date: current test can be upgraded with new biomarkers as soon as the benefits have been demonstrated.
